Award Data

The broader/commercial impact of this Small Business Innovation Research (SBIR) Phase II project is to bring new and more diverse audiences to circuit design and digital fabrication through an integrated STEAM (science, technology, engineering, art, and math) approach.Research shows that the STEAM approach is especially successful for reaching underrepresented minorities, girls, and women. This pr ...

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase II project is the development of a nanotechnology-based coating to combat the rise in Healthcare Acquired Infections (HAIs). HAIs spread in hospitals through healthcare workers’ hands and exposed surfaces. The coating technology developed through this project will disinfect surfaces contaminated with ...

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project addresses the societal need for a non-thermal, economical, and efficient solution for sterilizing deadly pathogens that are common in medical facilities and everyday living spaces. The commercial opportunity lies in developing a non-thermal, portable, safe, and economical sterilization device ...

The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase II project is to advance dynamic chemical reactor systems that repurposes waste gases (primarily carbon dioxide (CO2)) for use as fuels and as chemicals. This effort can have substantial commercial and market impacts as its output is compatible with existing infrastructure. This project leverages signif ...

The broader/commercial impact of this Small Business Innovation Research (SBIR) Phase II project is to address hardware security and trust issues that are threatening the semiconductor supply chain. Various threats exist from the design stage till the end of the life of chips, such as malicious logic insertion, intellectual property (IP) theft, reverse engineering, backdoor insertion, and informat ...

The European spongy moth (Lymantria dispar dispar ) (ESM) is a non-native insect pest withlarvae that feeds on leaves of over 300 broad-leaved species including forest shade ornamentaland fruit trees as well as shrubs. The spongy moth defoliated over 98 million acres of U.S.forests from 1924 to 2018. Current biological insecticides used in spongy moth control have notbeen efficacious enough and ch ...

AgIntel a spinoff company of the University of Florida (UF) has licensed two novel technologiesfrom UF: Agroview and AgroSense. Agroview a digital twin of an agricultural field can deliveraccurate zone-based fertility and prescription maps for precision nutrient applications. Agrosensecan convert a traditional fertilizer applicator (sprayer or spreader) to a smart machine for precisionnutrient app ...

Huanglongbingdisease("HLB")causedbythebacteriumCandidatusLiberibacterasiaticus ("CLas")haskilledmillionsofcitrustreesandreducedaverageyieldinFloridaby50%costing billionsinlostrevenue. CRISPRisthemostpowerfultoolforrapidbreedingofnewHLB-resistantcitrustreesbut hastobeprecededbyidentifyingspecificgene-editingtargets.Theidentificationoftargetgeneshas beenchallengingbecauseofpoorunderstandingoftheHLBp ...

ABSTRACT Pulmonary arterial hypertension (PAH) is a fatal disease (without curative therapies) that is critically influenced by dysregulated inflammatory pathways. This A1 R42 Fast Track STTR application focuses on eNAMPT (extra- cellular nicotinamide phosphoribosyltransferase) as a novel, highly attractive PAH target. Aqualung Therapeutics has developed a humanized eNAMPT-neutralizing mAb, ALT-10 ...

ABSTRACT Inflammatory bowel disease (IBD) is a debilitating disease (without curative therapies) that is critically influenced by dysregulated inflammatory pathways. This A0 R42 STTR application focuses on a highly novel humanized monoclonal antibody (mAb), ALT-100, to target and neutralize eNAMPT (extracellular nicotinamide phosphoribosyltransferase), a damage-associated molecular pattern protein ...